Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 100 of 132 publications.

Purser M, Mladsi DM, Kaye JA. Cost-effectiveness of sonidegib versus vismodegib for the treatment of patients with locally advanced basal cell carcinoma not amenable to surgery or radiotherapy. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 2, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A731.

Hoffman E, Mladsi DM, Cryer B, Hopkins W, Brater DC, Parikh R, Goyal R, Castellsague J, Stafkey-Mailey D, Young C. Dose-related risks of cardiovascular, gastrointestinal, and renal adverse events associated with meloxicam among patients with osteoarthritis: an observational study using US claims data. Poster presented at the 2016 ACR/ARHP Annual Meeting; November 15, 2016. Washington, DC. [abstract] Arthritis Rheumatol. 2016 Sep 28; 68(Suppl 10).

Boklage SH, Mangel AW, Ramamohan V, Mladsi D, Wang T. Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence. Patient Prefer Adherence. 2016 Jun 8;2016(10):1025-35. doi: 10.2147/PPA.S102760

Odom D, Mladsi DM, Purser M, Kaye JA, Palaka E, Charter A, Jensen JA, Sellami D. A matching adjusted indirect comparison of sonidegib and vismodegib in advanced basal cell carcinoma. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 23, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A122.

Herring W, Mladsi DM. External validation of health economic models for complex chronic diseases: lessons from a population model for diabetic retinopathy. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 23, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A88.

Boklage SH, Mangel AW, Ramamohan V, Mladsi D, Wang T. Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States. Patient Prefer Adherence. 2016 Jan 21;10:45-55. doi: 10.2147/PPA.S93320.

Mladsi D, Ramamohan V, Ronquest N, Boklage SH. A cost-consequences analysis of inpatient tolvaptan compared with fluid restriction among SIADH patients with hyponatremia. Poster presented at the 2015 AMCP Nexus; October 26, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10-a):S33.

Ramamohan V, Mladsi D, Ronquest N, Boklage S. A cost-consequences analysis of inpatient tolvaptan compared with fluid restriction among CHF patients with hyponatremia. Poster presented at the 2015 AMCP Nexus; October 26, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10-a):S53.

Mladsi DM, Goyal RK, Cryer B, Hopkins WE, Brater CD, Korsnes JS, Candrilli SD, Castellsague J, Varas-Lorenzo C. Risk of cardiovascular, gastrointestinal, and renal adverse events associated with diclofenac immediate and extended release drug products: an observational study using US claims data. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A292.

Herring WL, Grant TJ, Mladsi DM. A mathematical model to estimate the health benefits and costs of diabetic retinopathy screening programs. Presented at the 2015 Institute for Operations Research and Management Science Computing Conference; January 12, 2015. Richmond, VA.

Boklage SH, Mangel AW, Ramamohan V, Mladsi DM, Wang T. Effects of patient compliance on the cost-effectiveness of non-invasive tests for initial diagnosis of H. pylori infection in a high prevalence population. Poster presented at the 79th Annual Scientific Meeting of the American College of Gastroenterology; October 17, 2014. Philadelphia, PA.

Boklage S, Mangel AW, Ramamohan V, Mladsi DW, Wang T. Cost-effectiveness of noninvasive active tests for universal post-treatment confirmation of eradication of H. pylori infection. Poster presented at the 79th Annual Scientific Meeting of the American College of Gastroenterology; October 2014. Philadelphia, PA.

Purser MF, Mladsi DM, Wolowacz SE. A review of NICE technology appraisals using single-arm trials. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014. Montreal, Canada.

Odom DM, Mladsi DM, Saag KG, Sherif BN, Miles L, Ronquest N, Wang J. Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews. Clin Ther. 2014 Jun;36(6):906-17. doi: 10.1016/j.clinthera.2014.04.012.

Ramamohan V, Mladsi DM, Kaye JA, Boey W, Pozzi R. An outcomes model for high-risk non-muscle-invasive bladder cancer treatment options. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 2, 2014. Montreal, Canada. [abstract] Value Health. 2014 May; 17(3):A87.

Purser MF, Wilson MR, Mladsi DM, Wu Y. Literature review of economic models for the treatment of parkinson's disease. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 2, 2014. Montreal, Canada. [abstract] Value Health. 2014 May; 17(3):A60. doi: 10.1016/j.jval.2014.03.355

Mladsi DM, Ronquest NA, Tannus G, Fonseca M, Saag K. Estimated cost effectiveness of lower-dose submicron diclofenac compared with traditional diclofenac in Brazil. Poster presented at the 2013 ISPOR 4th Latin America Conference; September 2013. Buenos Aires, Argentina. [abstract] Value Health. 2013 Sep; 16(7):PA717-8. doi: 10.1016/j.jval.2013.08.2226

Odom DM, Mladsi DM, Saag K, Ronquest NA, Wang J. Estimating the relationship between diclofenac drug dosage and risk of gastrointestinal toxicity: meta-regression based on a systematic literature review. Poster presented at the 2013 Digestive Disease Week; May 2013. Orlando, FL. [abstract] Gastroenterology. 2013 May; 144(5 Suppl 1):S-673. doi: 10.1016/S0016-5085(13)62496-8

Herring WL, Mladsi DM, Miles L, Ronquest N. A novel approach to ranking parameter uncertainty in one-way sensitivity analysis: what tornado diagrams are missing. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 1, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A20.

Herring WL, Mladsi D, Mauskopf J. Patient-level simulation modeling for economic evaluations: opportunities and challenges in a practical setting. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 1, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A28-9.

Ronquest N, Mladsi D, Hopley C, Edgell E. The economic value of an innovative knee implant system for total knee arthroplasty. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 6, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A225.

Redekop WK, Mladsi D. The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health. 2013;16(Suppl 6):S4-9. doi: 10.1016/j.jval.2013.06.005.

Mladsi DM, Graham JB, Ronquest NA. Trade-off analysis: an extension of threshold pricing analysis. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 7, 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A169.

Mladsi D, Herring WL, Earnshaw S. Cost-effectiveness analysis in personalized medicine: general hypotheses and corresponding decision tree structures for screening, diagnostic, predictive, prognostic, surveillance, and monitoring tests. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 7, 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A168-9.

Mladsi D, Curtis S, Bell MJ, Ito T, Wilson M, Aboud M. Resource utilisation and cost of managing adverse events (AEs) associated with highly active antiretroviral therapy (HAART) in patients with HIV-1. Poster presented at the 18th Annual Conference of the British HIV Association; April 1, 2012. Birmingham, UK. [abstract] HIV Med. 2012 Apr 18; 13(SI):17-8.

Mladsi D. Linking product attributes with a threshold pricing model: how commercial thresholds can inform the drug discovery process. Presented at the 2012 DIA 24th Annual EuroMeeting; March 2012. Copenhagen, Denmark.

Brogan AJ, Deniz B, Miller JD, Mladsi DM, Herring WL, Thompson JR. Cost-effectiveness assessment of telaprevir combination therapy compared with pegylated interferon and ribavirin alone in the management of chronic hepatitis C virus infection in Canada. Poster presented at the 2012 Canadian Digestive Diseases Week and the Annual Winter Meeting of the Canadian Association for the Study of the Liver; February 24, 2012. Montreal, Canada. [abstract] Can J Gastroenterol. 2012 Feb; 26(Suppl(SA)).

Spinner DS, Mladsi D, Walter J, Ziemiecki R, Stafford-Smith M, Taekman J, Faulkner E. Clinical trial learning curves may impact both clinical and economic outcomes and influence health technology assessment and reimbursement decision making. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A356.

Mladsi DM, Redekop K, Goettsch A, Earnshaw SR. Challenges and insights in establishing and communicating the economic value of companion diagnostics. Presented at the 2010 ISPOR 13th Annual European Congress; November 2010. Prague, Czech Republic.

Mladsi D, Earnshaw S, Ronquest NA, Keith M. The threshold pricing model: not just another cost-effectiveness model. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A332.

Mladsi D, Earnshaw S, Akashi-Ronquest N, Keith M. Proposed methods for conducting sensitivity analyses on threshold-derived estimates of value-based price and product profiles of early stage drugs. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A333.

Mladsi D. Review of utility estimates in atopic dermatitis. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A402.

Juniper M, Le TK, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opin Pharmacother. 2009 Nov 1;10(16):2581-92. doi: 10.1517/14656560903304063.

Odom DM, Bennett L, Irish W, Mladsi DM. Statistical methods to handle incomplete longitudinal patient-reported outcomes data in advanced disease stage trials. Presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, France.

Mladsi D, de Cambra S, Gilabert-Perramon A, Faulkner EC. Orphan drug funding: a model for personalized medicine? Presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, France.

de Cambra S, Mladsi D, Neale S, Faulkner EC. Reimbursement of active immunotherapeutics: an analysis based on a study of current reimbursement approaches. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. Paris, France. [abstract] Value Health. 2009 Oct; 12(7):A288. doi: 10.1111/j.1524-4733.2009.00592_1.x

de Cambra S, Mladsi D, Neale S. International payer research: comparing and contrasting payer roles and research methods in Canada, Spain, and the UK. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. Paris, France. [abstract] Value Health. 2009 Oct; 12(7):A245. doi: 10.1111/j.1524-4733.2009.00592_1.x

Le TK, Roskell NS, Mladsi DM, Mitra D, Shannon PR, Wilson AG, Juniper MD. Database analysis to estimate medical and pharmacotherapy resource utilization and costs of fibromyalgia prior to and following diagnosis in the United Kingdom primary care setting. Poster presented at the 25th Annual Meeting of the American Academy of Pain Medicine; January 2009. Hawaiian Village, Honolulu, HI.

Mladsi DM, Palmer WN, Miller D. Threshold pricing analysis: an economist's contribution to pharmaceutical pricing. Presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece.

Mladsi DM, Irish WD, Copley-Merriman K, Bhandary D. Statistical measures of treatment effects in oncology: what are we missing? Presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece.

Mladsi DM, Juniper MD, Roskell NS, Mitra D, Shannon PR, Wilson A, Garcia Cebrian A, Le KT. Pharmacological management of fibromyalgia in UK primary care. Poster presented at the19th Annual Clinical Meeting of the American Academy of Pain Management; September 2008. Nashville, TN.

Mladsi DM, Juniper MD, Roskell NS, Mitra D, Shannon PR, Wilson AG. The pharmacological management of fibromyalgia syndrome in the UK primary care setting. Presented at the Annual Congress of the European League Against Rheumatism; June 2008. Paris, France.

Juniper MD, McCrink L, Mladsi DM, Le TK. The burden of fibromyalgia in France, Germany, Italy, Spain, and the UK: a literature-based review. Poster presented at the Annual Congress of the European League Against Rheumatism; June 2008. Paris, France.

Mladsi DM. MMA Part D: how has the US market changed? Presented at the Visiongain 4th Annual Pricing and Reimbursement Conference; May 26, 2006. London, UK.

Mladsi DM, Barrett AM. Winners and losers: patterns in economic evaluations of anti-epileptic drugs. Poster presented at the 2006 ISPOR 11th Annual International Meeting; May 20, 2006. Philadelphia, PA. [abstract] Value Health. 2006 May; 9(3):A83.

Mladsi DM. Developing health economic models for assessing cost-effectiveness and product value. Presented at the 2006 Health Economics Conference; April 28, 2006. London, UK.

Gregson N, Sparrowhawk K, Mladsi DM. Global pricing and reimbursement strategy: an integrated analytical framework. Presented at the 2005 ISPOR 8th Annual European Congress; November 8, 2005. Florence, Italy.

Johnson FR, Mladsi DM, Sparrowhawk K. Conjoint analysis: application to global pricing and reimbursement strategy. Presented at the 2005 ISPOR 8th Annual European Congress; November 7, 2005. Florence, Italy.

Lucero MA, Mladsi D, Mauskopf J. Communicating the value: developing messages for payers. Presented at the 2004 ISPOR 7th Annual European Congress; October 24, 2004. Hamburg, Germany.

West R, Curry SJ, Fiore MC, Sullivan SD, Neighbors D, Gilsenan AW, Smadja E, Lavaud V. Attempt cohort: weight gain concern of smokers intending to quit. Poster presented at the 10th Annual Scientific Sessions of the Society for Research on Nicotine and Tobacco; February 2004. Scottsdale, AZ.